A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism
dc.contributor.author | Bayhan G. | |
dc.contributor.author | Bahçeci M. | |
dc.contributor.author | Demirkol T. | |
dc.contributor.author | Ertem M. | |
dc.contributor.author | Yalinkaya A. | |
dc.contributor.author | Erden A.C. | |
dc.date.accessioned | 2024-04-24T18:43:59Z | |
dc.date.available | 2024-04-24T18:43:59Z | |
dc.date.issued | 2000 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: To compare the efficacy of finasteride and GnRH agonist in the treatment of idiopathic hirsutism. Methods: Sixty women with hirsutism were randomly assigned to receive either 5 mg of finasteride or long-acting GnRH agonist (depot leuprolide 3.75 mg) intramuscularly monthly for six months. Main outcome measures: Hirsutism scores were measured according to the Ferriman-Gallway scoring system, and side-effects were monitored for six months of treatment. Blood samples were taken at each visit for assessment of endocrine (FSH, LH, estradiol, progesterone, total and free testosterone, androstenedione, DHEAS-S, 17-OH-P, SHBG), biochemical, and hematologic parameters. Results: All of the patients treated with finasteride or GnRH agonist showed neither menstrual abnormalities nor side-effects. The mean percent change (±SD) in hirsutism scores in the GnRH and finasteride groups was 36%±14% and 14%±11% at six months, respectively. Serum total testosterone, free testosterone, androstenedion and DHEA-S showed a meaningful decrease in patients treated with GnRH agonist. On the other hand, only serum total testosterone and free testosterone levels decreased with finasteride treatment (p<0.05 and p<0.0001, respectively). | en_US |
dc.identifier.endpage | 206 | en_US |
dc.identifier.issn | 0390-6663 | |
dc.identifier.issue | 3-4 | en_US |
dc.identifier.pmid | 11214952 | |
dc.identifier.scopus | 2-s2.0-0034477080 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 203 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/24498 | |
dc.identifier.volume | 27 | en_US |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.relation.ispartof | Clinical and Experimental Obstetrics and Gynecology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Androgens | en_US |
dc.subject | Estrogen Replacement | en_US |
dc.subject | Finasteride | en_US |
dc.subject | Gnrh Agonist | en_US |
dc.subject | Idiopathic Hirsutism | en_US |
dc.subject | Leuprolide Acetate | en_US |
dc.title | A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism | en_US |
dc.title | A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism | |
dc.type | Article | en_US |